Kraig Biocraft Laboratories, Inc.
KBLB
$0.09
$0.0055.88%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.44% | 93.91% | 90.44% | 28.98% | 22.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.58% | 82.78% | 78.55% | 24.95% | 23.26% |
| Operating Income | -17.58% | -82.78% | -78.55% | -24.95% | -23.26% |
| Income Before Tax | -12.19% | -46.00% | -36.90% | 11.64% | 21.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.19% | -46.00% | -36.90% | 11.64% | 21.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.19% | -46.00% | -36.90% | 11.64% | 21.14% |
| EBIT | -17.58% | -82.78% | -78.55% | -24.95% | -23.26% |
| EBITDA | -17.83% | -83.89% | -79.50% | -25.27% | -23.59% |
| EPS Basic | -10.34% | -48.00% | -35.71% | 12.12% | 25.64% |
| Normalized Basic EPS | -16.67% | -50.00% | -33.33% | 22.73% | 28.00% |
| EPS Diluted | -10.34% | -48.00% | -35.71% | 12.12% | 25.64% |
| Normalized Diluted EPS | -16.67% | -50.00% | -33.33% | 22.73% | 28.00% |
| Average Basic Shares Outstanding | 0.51% | 0.80% | 2.08% | 3.96% | 6.28% |
| Average Diluted Shares Outstanding | 0.51% | 0.80% | 2.08% | 3.96% | 6.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |